Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average
The Nasdaq 100 trades at records Monday, yet 55 of its 101 stocks sit below their 50-day average. QQQ has beaten equal-weight QQQE by 8% since late July.
Stocks · News reference
This Hewlett Packard Enterprise Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Analysts upgraded HPE, Abbott, Airbnb, Horizon Bancorp and Triumph Financial, raising or setting price targets and issuing more bullish ratings.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Assessing Airbnb's Performance Against Competitors In Hotels, Restaurants & Leisure Industry
In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating
Keybanc Upgrades Airbnb to Overweight, Announces $191 Price Target
Keybanc analyst Sergio Segura upgrades Airbnb (NASDAQ:ABNB) from Sector Weight to Overweight and announces $191 price target.
Abbott shares are trading higher after the company received FDA approval for CardioMEMS HF System updates that add new patient-facing features through the CardioGuide HF App.
Europe Point of Care Diagnostics Market Size and Forecast, 2021 - 2031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR
Europe's Point of Care (POC) Diagnostics Market is projected to grow from US$8.9 billion in 2024 to US$21.4 billion by 2031, with a 13.4% CAGR driven by rapid testing innovation, molecular diagnostics advancement, and increasing prevalence of infectious and chronic diseases. Germany leads the regional market, supported by strong healthcare infrastructure and public health initiatives. Key players include Siemens AG, Abbott Laboratories, Roche, bioMerieux, Bio-Rad, QIAGEN, Nova Biomedical, Polymer Technology Systems, and Danaher Corp.
FDA Approves Abbott's Updated CardioMEMS HF System